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Objective: To investigate the clinical effects of electroacupuncture (EA) on the head points for improving 
gnosia in patients with vascular dementia (VD). Methods: 90 VD patients were randomly divided into a drug 
group, an EA group and an EA plus drug group. Scoring with the MMSE scale and detecting the relevant 
potentials were done before treatment and after a 6-week treatment. Results: Gnosia was improved after 
treatment in all the three groups with no significant difference by the intergroup comparison. Conclusion: 
The above three therapies can all improve gnosia, reduce the psychological stress, strengthen attention and 
shorten the awaiting time for recognition; and EA plus Nimodipine seems to be the best in the curative effect.  
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Vascular dementia (VD) refers to a clinical syndrome 
of cognitive dysfunction caused by the 
cerebrovascular diseases. It is a chronic progressive 
disorder manifested mainly by reduction or 
disappearance of memory, cognition, language, 
disposition, behavior, judgment, attention and logic 
inference.1 The epidemiology survey shows that there 
are more than 4.2 million VD patients in China with 
an incidence of 324/100,000 in the old people.2 The 
authors have comprehensively analyzed and 
evaluated the articles published in the past 55 years 
on acupuncture treatment of VD. The present study 
was designed to evaluate the therapeutic effects and 
safety of electroacupuncture on the head points for 
improving gnosia in VD patients.  
CLINICAL MATERIALS
In this series, all the 90 cases of VD were the out- or 
in- patients of the Hospital Affiliated to Chengdu 
University of Traditional Chinese Medicine admitted 
from February 2004 to January 2006. 
Criteria for admission 
1) The patients conforming to the DSM-IV3
diagnostic criteria and having dementia for more than 
6 months; 2) The patients conforming to 
NINDS/AIREN4 diagnostic criteria for vascular 
dementia; 3) The patients with HIS score 7; 4) The 
patients with mild dementia (CDR=1.0) and moderate 
dementia (CDR=2.0); 5) The patients aged 45–80, 
and with menopause for over 1 year in females; 6) 
The patients who can coordinate well with the 
researchers and voluntarily sign a fact-known 
consent. 
Criteria for exclusion 
1) The patients with Alzheimer’s disease or with 
dementia caused by other factors; 2) The patients 
with HIS score <7; 3) The patients with CSDD5 score 
>8 and diagnosed by DSM-IV as having obvious 
mental depression, or the patients with other mental 
disease or disorder; 4) The patients with severe 
internal diseases or severe neural dysfunction, such 
as malignant tumor, aphasia, dysopia and dysacusis; 5) 
The patients under 45 or over 80 years of age; 6) The 
patients unable to complete detection of the relevant 
potentials. 
Randomly grouping
The SAS statistic analysis system was used. The 90 
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patients were randomly divided into a drug group, an 
electroacupuncture group and an electroacupuncture 
plus drug group. The patients’ clinical data were 
coded from 01 to 90 and sealed in a light-proof 
envelope. And the researchers, case collectors and 
physicians worked separately with the technicians 
responsible for data statistics and evaluations. 
The experimental drug and medical apparatus 
used
Nimodipine, 20 mg/tablet, was produced by Shanxi 
Yabao Pharmaceutical Group with a batch number 
H14022821. The No. 30 stainless steel filiform 
needles, 1 or 1.5 cm in length, were produced by 
Suzhou Medical Apparatus Company. The 
G6805- electric stimulatorĊ  was produced by 
Shanghai Medical Instrument Factory.  
METHODS 
In order to ensure the health and safety of the patients, 
hypotensor, hypoglycemic agent, lipid-reducing agent 
and other drugs with no relation to VD treatment 
were not specifically restricted. However, vasodilator, 
cholinesterase inhibitor, glutamic acid antagonist and 
the brain-protecting drug should not be used.  
Point selection 
According to the authors’ previous research results of 
“clinical superior plan on VD treatment”, Sishencong 
(EX-HN1), Baihui (GV 20), Shenting (GV 24) and 
Fengchi (GB 20), located on the head and used most 
frequently, were selected. 
1) For the electroacupuncture group: The patient took 
a setting position with the back against the chair. The 
points were routinely sterilized with 75% alcohol. 
And the needles were obliquely inserted into galea 
aponeurotica at the angle of 15–30 degrees. Fengchi
(GB 20) was obliquely punctured 0.5–1.2 cun deep in 
the direction to the nose tip. The needles were 
inserted in forward direction at Shenting (GV 24), 
front Shencong and Baihui (GV 20). And the left, 
right and rare Shencong were punctured 0.5–1.2 cun
deep in the direction to Baihui (GV 20). After the 
needling sensation was felt, the needle handles were 
connected to a G6805-Ċ electric stimulator with the 
continuous wave at a frequency of 300–500/ min and 
the intensity tolerable to the patient. The treatment 
was given once a day, 30 min each session, 5 times a 
week (with a 2-day interval at the weekend) for 6 
weeks.  
2) For the drug group, Nimodipine tablet was orally 
taken 20 mg a time, 3 times a day, for 6 weeks 
without interval.  
3) For the electroacupuncture plus drug group, the 
above 2 methods of 1) and 2) were used together.  
The indexes observed 
1. Observation of safety 
1) General examination: body temperature, blood 
pressure, pulse and respiration. 2) Blood routine tests. 
3) Functional examinations for the liver and kidney. 
The above items were detected and recorded once the
7th day respectively before and after treatment. 
2. Observation of curative effect 
Evaluation of gnosia: 
The MMSE scale was used to evaluate gnosia one 
day before treatment and the 2nd day after treatment. 
All the detections were carried out in a quiet 
environment with sufficient light in the room so that 
the subjects could clearly see the pictures, and with 
no unexpected interference. The evaluations were 
done by the physicians, trained psychologically and 
unrelated to the present research. 
Detection of the gnosia-induced potential P300: 
The MEB-2200 electromyogram/evoked poten- 
tiometer produced by Japanese Nihon Kohden 
Company were operated by professional physicians 
from the Electrophysiological Detection Department. 
After a stable P300 had been recorded on the screen, 
the latent period (LP) and amplitude of P300 peak 
were detected and the LP of N1, P2 and N2 peak 
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recorded. The detection was done 1 day before 
treatment and the 2nd day after treatment.  
Dnnetection of the connected negative variation 
(CNV): 
The detection was also operated by professional 
physicians from the Electrophysiological Detection 
Department. After a stable CNV had been recorded 
on the screen, the LP of points A and C, amplitude of 
point B and areas of the A-S2’, S2’-C and A-C figures 
were detected, which were done 1 day before 
treatment and the 2nd day after treatment for the 
statistical analysis. 
Criteria for evaluating therapeutic effects 
1) The “Criteria for Diagnosis, Syndrome- 
differentiation and the Therapeutic Effects on VD” 
stipulated by the Anti-aging Committee of China 
Association of Chinese Medicine were adopted. 
Markedly relieved: the index of curative effect (ICE) 
20%. Improved: ICE 12%. Failed: ICE <12%. 
Deteriorated: ICE >-12%. The ICE for gnosia = (The 
accumulated score (AC) after treatment – AC before 
treatment)/AC before treatment × 100%.  
2) The changes in LP of N2, P3a and P3b and the 
amplitude of N2-P3b were observed before and after 
treatment.  
3) The LP of points A and C, the amplitude of point B 
and the areas of A-S2’, S2’-C and A-C figures were 
detected before and after treatment. 
Statistical analysis  
The SPSS12.0 software was used for statistical 
analysis. Normal test was done for the measurement 
data; and One-way ANOVA was made for the 
measurement data conforming to normal distribution, 
with q test used for the paired comparison. The 
non-parametric test was used for the measurement 
data not conforming to normal distribution. Ȥ2 test 
was used for enumeration data, and the rank test for 
grade data. P<0.05 was taken as a significant 
difference. 
RESULTS 
In this series of 90 patients, 73 cases completed the 
whole process of the research, 6 cases quitted and 11 
cases were rejected from the research. 
Baseline analysis
There was no significant difference among the 3 
groups in sex, age, cultural level and extent of VD. 
Thus it can thus be seen that the patients were evenly 
grouped with good baseline and comparability 
(P>0.05). 
Comparison of the therapeutic effects 
In terms of improving gnosia of VD patients, the total 
effective rate was 66.7% in the drug group, 73.9% in 
the electroacupuncture group, and 76.9% in the EA 
plus drug group. There was no significant difference 
among the 3 groups in curative effect (P>0.05). 
Comparison of the total and respective scores for 
MMSE before and after treatment 
As shown in Table 1, for the intergroup comparison, 
there is no significant difference in the MMSE total 
scores among the three groups either before or after 
treatment (P>0.05), but very significant difference 
was found in all the three group before and after 
treatment (P<0.01). Table 2 shows that there is no 
difference in gnosia score for the intergroup 
comparison among the 3 groups either before or after 
treatment (P>0.05), but very significant difference 
was found in all the three groups for the intragroup 
comparison before and after treatment (P<0.01). 
There is a very significant difference in memory 
score in all the three groups for the intragroup 
comparison before and after treatment (P<0.01); and 
a significant difference was found between the EA 
plus drug group and the other 2 groups (P<0.05). 
There is no obvious difference in language score for 
the intergroup comparison among the 3 groups either 
before or after treatment (P>0.05); but very 
significant difference was found in the drug group for 
the intragroup comparison before and after treatment 
(P<0.01), significant difference in the EA plus drug 
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group (P<0.05) and no difference in the EA group 
(P>0.05). There is a significant difference in spatial 
vision score in all the three groups for the intragroup 
comparison before and after treatment (P<0.05), but 
with no significant difference among the 3 groups for 
the intergroup comparison (P>0.05). 
Table 1. Comparison of the total scores for MMSE before and after treatment in the 3 groups ( x fs)
Group n Pretreat. Posttreat. 
Drug group 24 19.75±5.67 23.96±4.37** 
EA group 23 20.13±3.90 23.57±3.17** 
EA plus drug group 26 18.85±4.84 22.81±5.30** 
Note: For the intragroup comparison, **P<0.01. 
Table 2. Comparison of item scores of MMSE scale before and after treatment in the 3 groups ( x fs)
Gnosia score Memory score Language score Spatial vision score 
Group n 
Pretreat. Posttreat. Pretreat. Posttreat. Pretreat. Posttreat. Pretreat. Posttreat. 
Drug group 24 9.75±4.48 12.17±3.07** 3.63±1.28 4.33±1.44** 3.42±0.88 4.04±0.81** 4.17±1.01 4.71±0.75*
EA group 23 10.30±2.57 12.39±2.04** 3.57±1.16 4.26±1.05** 3.39±0.78 3.57±0.90** 4.09±1.47 4.48±1.04*
EA plus 
drug group
26 9.85±2.87 11.61±3.03** 2.92±1.44 4.19±1.23** 3.27±0.78 3.69±1.05** 3.81±1.23 4.35±1.44*
Note: For the intragroup comparison, *P<0.05, and **P<0.01. 
The P300 (Pz) detection before and after 
treatment 
It can be seen from Table 3 that the latent period was 
prolonged and the amplitude lowered in all the 3 
groups but with no significant difference for the 
intergroup comparison, hence comparable among the 
three groups (P>0.05). In EA plus drug group, there 
was a very significant difference in the latent period 
of P3a and P3b (P<0.01) and significant difference in 
the amplitude of N2-P3b (P<0.05).  
The CNV (Pz) detection before and after 
treatment 
It can be seen from Table 4 that before treatment, the 
latent period was prolonged, and the amplitude 
lowered with enlarged area in all the three groups but 
with no significant difference for the intergroup 
comparison, hence comparable among the three 
groups (P>0.05). There were significant differences 
in the latent period of A and in the areas of A–S2’ and 
A–C for the intragroup comparison after treatment in 
all the 3 groups (P<0.05). There was a significant 
difference in the area of A–S2’ after treatment 
between the drug and the EA groups and between the 
drug and the EA plus drug groups (P<0.05). There 
was a significant difference in the area of A–C and in 
the latent period of A after treatment between the 
drug group and the EA groups (P<0.05). In the drug 
group, there was very significant difference in the 
area of A–S2’ (P<0.01) and a significant difference in 
the area of A–C (P<0.05) for the intragroup 
comparison before and after treatment.  
Safety analysis
In this series of 90 VD patients, no adverse reactions 
were found in the life signs, blood routine, liver and 
kidney functions. And during EA, no patients 
suffered from faint, stuck needle, bent needle, broken 
needle, and with no hematoma, infection and injury 
at acupunctured sites. Only one patient had fever on 
the third day of treatment, but with no direct relation 
to EA therpay.  
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Table 3. The P300 (Pz) detection before and after treatment in the 3 groups ( x fs)
Latent period (ms) Amplitude (μv) 
Group n Time 
N2 P3a P3b N2-P3b 
Pretreat. 241.12±24.32 318.68±49.83 404.30±53.58 7.51±3.89 drug group 25
Posttreat. 246.17±28.07 326.43±56.53 410.70±71.42 8.43±5.35 
Pretreat. 247.27±47.36 306.64±41.20 377.53±41.81 7.99±5.11 EA group 22
Posttreat. 237.23±23.29 314.82±59.78 387.24±80.50 8.71±6.78 
Pretreat. 253.68±45.44 330.38±52.92 412.58±63.80 9.28±5.79 EA plus drug group 25
Posttreat. 242.40±26.68 317.58±41.67** 383.96±37.51** 11.60±7.08* 
Note: For the intragroup comparison, *P<0.05, and **P<0.01. 
Table 4. The CNV (Pz) detection before and after treatment in the 3 groups ( x ±s). 
Latent period (ms) Amplitude (μV) Area (μV2) 
Group n Time A C A –B A–S2’ S2’–C A–C 
Pretreat. 358.82±119.94 2273.20±166.40 15.01±7.43 9.59±4.79 2.01±1.49 11.61±5.65 Drug group 14
Posttreat. 430.64±168.72 2265.20±200.42 12.12±7.94 6.40±3.15** 1.58±1.98 7.98±4.78*
Pretreat. 355.00±146.99 2222.10±60.31  11.93±5.713 9.70±6.673 1.76±1.37 11.45±7.65 EA group 14
Posttreat. 300.71±80.43 2182.90±60.37  9.67±4.77 11.90±8.87 4.09±7.29 15.99±14.11
Pretreat. 390.00±165.40 2237.10±98.14 15.14±9.99 15.55±14.27 2.72±2.88 18.27±16.24EA plus 
drug group
16
Posttreat. 348.69±167.63 2233.10±88.81 12.23±6.40 10.19±5.55 1.96±1.59 12.15±6.51 
Note: For the intragroup comparison, *P<0.05, and **P<0.01. 
DISCUSSION 
TCM holds that deficiency of essence and qi of the 
kidney and stagnation of phlegm with blood stasis in 
the channels are the basic cause for VD. The 
pathogenesis of VD with its focus in the brain lies in 
malnutrition of brain and stagnation of phlegm with 
blood stasis due to the old age, weak body, deficiency 
of the kidney essence and deficiency of the spleen 
with insufficiency qi and blood. 6-8  
Nimodipine, a calcium antagonist used in the present 
study, had been proved to be very effective for 
improving gnosia in VD patients.9 The point 
prescription for EA was made according to the “Best 
Choice for Acupuncture Treatment of VD”.10
Acupuncture at Baihui (GV 20) can nourish qi, 
strengthen yang, tonify the brain and marrow, 
tranquilize the mind and improve gnosia. Modern 
research shows that acupuncture at Baihui (GV 20) 
can obviously strengthen the memory. 11 Acupuncture 
at Sishencong (EX-HN1) can make people intelligent, 
regulate yin and yang, strengthen yang-qi, 
supplement brain and calm the mind. Shenting is 
usually used for treating the mental disorders. 
Fengchi (GB 20) can be used for restoring 
consciousness, inducing resuscitation, and improving 
eyesight. Modern research has demonstrated that 
acupuncture at Fengchi (GB 20) can make the 
needling sensation reach the medullary center and 
directly improve the cerebral functions. 12  
The results of the present study show that both EA 
and Nimodipine can improve gnosia in VD patients, 
and EA plus Nimodipine may show better effect in 
improving memory. The results of the relative 
potential P300 suggest that EA plus Nimodipine may 
improve the positioning activity of the cortex, and 
improve gnosia and judgment of the VD patients. The 
decrease in the latent period of A and C of CNV, the 
reduction in the amplitude of B wave and the 
enlargement in the area of negative change found in 
the present study are identical to those reported in the 
literature,13 indicating that all the three therapies can 
lessen psychological burden of the VD patients, 
strengthen their attention, and the shorten awaiting 
time for recognition. 
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